TEVA (Teva Pharmaceutical Industries Ltd.) שולי הרווח הגולמי

Teva Pharmaceutical Industries (TEVA) competes through scale and cost control while operating under severe pricing pressure from regulators. The gross profit margin on the GURU.Markets chart visualizes production efficiency, where 53.50 captures the current value of the indicator. Stable demand for affordable medications makes the holding's business resilient to macroeconomic shocks and market cycles.
פילוחים אנליטיים ודוחות נתונים של חברת Teva Pharmaceuticals (TEVA)

As a price-taker in the generics market, Teva Pharmaceutical Industries (TEVA) depends on external pricing conditions despite its colossal production volumes. Gross margin measures the portion of revenue remaining after covering direct production costs, reflecting the efficiency of cost-of-goods-sold management. For the investor, this indicator serves as a quality-of-growth filter, identifying the risk of profit erosion amid rising competition. The trend of the gross profit-to-revenue ratio on this chart allows for a real-time assessment of the business model's resilience.